Pierrel operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other pharmaceutical manufacturers in Europe: Science In Sport Plc of the United Kingdom (2017 sales of £15.62 million [US$20.25 million] of which 89% was Core), Replek AD Skopje of Macedonia (955.23 million Denar [US$17.63 million] ), and Photocure ASA which is based in Norway (150.91 million Norwegian Kroner [US$17.89 million] of which 57% was Hexvix/Cysview Own Sales).

Sales Analysis. During the year ended December of 2017, sales at Pierrel were 16.84 million Euro (US$19.09 million). This is an increase of 18.0% versus 2016, when the company's sales were 14.27 million Euro.